SAM
ADMS

Sectoral Asset Management’s Adamas Pharmaceuticals ADMS Stock Holding History

Sectoral Asset Management’s Portfolio ADMS Stock Details ADMS Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2019
Q2 		– Sell
-808,924
Closed -$5.75M – 106
2019
Q1 		$5.75M Sell
808,924
-325,000
-29% -$2.92M 0.69% 53
2018
Q4 		$9.68M Buy
1,133,924
+230,500
+26% +$3M 1.32% 27
2018
Q3 		$18.1M Buy
903,424
+367,904
+69% +$8.64M 1.92% 17
2018
Q2 		$13.8M Buy
535,520
+184,200
+52% +$5.1M 1.55% 28
2018
Q1 		$8.4M Buy
+351,320
New +$11.1M 0.92% 43

Other funds holding ADMS

AC
Armistice Capital New York $5.62B AUM 36.06% 1-Year Est. Return
Macquarie Group
Macquarie Group Sydney, NSW 2000, Australia $16.8B AUM 27.39% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
SCM
Stonepine Capital Management Bend, Oregon $250M AUM 77.6% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Ameriprise
Ameriprise Minneapolis, Minnesota $432B AUM 30.22% 1-Year Est. Return
EA
Emerald Advisers Leola, Pennsylvania $3.16B AUM 109.58% 1-Year Est. Return
EMFAT
Emerald Mutual Fund Advisers Trust Leola, Pennsylvania $2.06B AUM 106.87% 1-Year Est. Return
DAM
Deltec Asset Management New York $677M AUM 31.67% 1-Year Est. Return
BC
Broadfin Capital New York $747M AUM 100.56% 1-Year Est. Return

Sectoral Asset Management's ADMS Position: Q2 2019 in Review

Sectoral Asset Management sold out of Adamas Pharmaceuticals (ADMS) in Q2 2019, closing a stake of 808,924 shares — an estimated $5.75M sold.

Sectoral Asset Management first reported a position in ADMS in Q1 2018 and held it in 5 quarters. The position peaked at $18.1M in Q3 2018. 78 funds tracked by Wall St. Rank hold ADMS as of Q2 2019.

  • Sectoral Asset Management reported no remaining Adamas Pharmaceuticals position as of Q2 2019 after selling out during the quarter.
  • Sectoral Asset Management sold 808,924 Adamas Pharmaceuticals shares in Q2 2019, an estimated $5.75M.
  • Sectoral Asset Management first reported a position in Adamas Pharmaceuticals in Q1 2018 and held it in 5 quarters.
  • Sectoral Asset Management's Adamas Pharmaceuticals position peaked at $18.1M in Q3 2018.
  • 78 funds tracked by Wall St. Rank held Adamas Pharmaceuticals as of Q2 2019.

Based on Sectoral Asset Management's 13F filing for Q2 2019, filed 14 Aug 2019.